Brief: Theranexus ‍Announces Successful Study In Development Of THN201 And THN101​

Thx Pharma SA

21/03/2018 06:51

March 21 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * ‍ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS
PART
OF DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101​

Source text for Eikon:  ID:nACT52439 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))